Q
Qantev
AI platform automating health insurance claims management
About Qantev
Qantev is a French insurtech company that has developed an artificial intelligence (AI) platform to optimize health and life insurance claims management. Founded in Paris in 2019 by Tarik Dadi (CEO) and Hadrien de March (CTO), the company aims to address the growing complexities and costs in the health insurance sector. Dadi's background includes leading data science projects at AXA, while de March holds a PhD from École Polytechnique and began his career as a quantitative analyst at Goldman Sachs.
Read full description
The company provides a modular, end-to-end software-as-a-service (SaaS) platform for global insurers like AXA and Generali. Its core function is to automate and streamline the entire claims lifecycle. The technology uses specialized AI, machine learning, and medical language processing to digitize and analyze claims documents, including handwritten text. Key features include automated data extraction (OCR), medical coding inference, fraud, waste, and abuse detection, and checks for policy coverage and medical necessity. By transforming unstructured data into actionable insights, Qantev helps insurers reduce manual processing, lower claims costs, improve loss ratios, and enhance customer satisfaction through faster processing times. The platform is designed for rapid deployment, typically within four to six months.
Qantev has expanded its operations internationally, with a presence in Europe, North America, and Asia, and offices in Paris and Hong Kong. The company has secured significant funding to fuel its growth, including a €1.5M seed round in 2020, a €10M Series A in October 2022, and a €30M round led by Blossom Capital in September 2024, bringing its total funding to over €40 million. These funds are allocated to enhancing the platform's AI capabilities, recruiting talent, and accelerating global expansion. In February 2025, Qantev announced a strategic partnership with INSTANDA, a no-code policy administration platform, to offer a comprehensive end-to-end solution for life and health insurers.
At a glance
- Status
- Operational
- Founded
- 2019
- Headquarters
- Paris, France
- Employees
- 40
- Open positions
- 4
- Dealroom signal
- 61.5/100
- Industry
- Fintech
- Sub-industry
- Insurance
- Sector
- Fintech, Analytics, Core AI, Insurtech Claim, Health Insurance, LandH Insurance, biotech medtech and e-health, Observatoire Deeptech
- Technology
- Artificial Intelligence, Deep Tech, Machine Learning
- Business model
- SaaS
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Sep 2024 | $33M | $132M | Elaia · Omnes Capital · RAISE Ventures · Blossom Capital | ↗ |
| SERIES A✓Equity / VC | Oct 2022 | $11M | $44M | Elaia · Omnes Capital · RAISE Ventures | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Qantev is 1.7K monthly website visits, down 46.9% over the last three months. Qantev's team declined 21.6% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
CardioLogsDemocratizes expert cardiac care globally, by empowering all actors in the care chain with AI |
Paris, France | Closed | 64 | $23M | $60M |
PixylNeuroimaging AI for Improved Patient Care |
La Tronche, France | Acquired | |||
THERAPANACEADevotion to Innovation, Compassion for Patients, Artificial Intelligence for Cancer Care |
Paris, France | Operational | |||
ImvitroCombines the power of cell culture and artificial intelligence to tackle infertility |
Paris, France | Operational | |||
Volta MedicalA med-tech company based in Marseille that develops artificial intelligence (AI) intended for interventional cardiology |
Marseille, France | Operational | |||
Keen EyeAnalyzes and reviews slide images |
Paris, France | Closed | |||
Avicenna.aiAI solutions for emergency radiology and incidental findings |
La Ciotat, France | Operational | |||
SquareMindCreating autonomous robots that will help healthcare professionals save time and improve patient care |
Paris, France | Operational |
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
Elaia
Entrepreneurs First
Series A3 investors entered at this stage
Omnes Capital
RAISE Ventures
Blossom Capital
Other known investors2 additional known investors
Gwénaël Moy
Hugo Hubert
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Qantev on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Qantev’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







